The Straits TimesHealth
Novartis heart drug misses trial goal
Novartis and Ionis said their heart drug failed to meet the trial’s primary goal, adding uncertainty to research into new treatments. The brief announcement offers no further details on the results or what comes next.
This card is an AI-assisted summary of reporting published by The Straits Times. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.